These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 358696)

  • 1. [Relationship between bacteriocinogenic and non-bacteriocinogenic streptococcal cultures in experiments in vivo].
    Kolesnichenko TG; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):97-101. PubMed ID: 358696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistence of Streptococcus pyogenes].
    Dmitrieva NF; Timofeev IuM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):104-9. PubMed ID: 19621829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Streptococcus pyogenes--pathogenetic factors and their involvement in the pathogenesis of acute streptococcal infections and their complications].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):34-47. PubMed ID: 8173211
    [No Abstract]   [Full Text] [Related]  

  • 4. Interference by an alpha-hemolytic streptococcus of beta-hemolytic pathogenic streptococci.
    Beck A
    Inflammation; 1979 Sep; 3(4):463-5. PubMed ID: 389799
    [No Abstract]   [Full Text] [Related]  

  • 5. Uveitis: an isolated complication of post-streptococcal syndrome.
    Fretzayas A; Moustaki M; Stefos E; Dermitzaki E; Nicolaidou P
    Ann Trop Paediatr; 2010; 30(2):153-5. PubMed ID: 20522303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
    O'Connor SP; Cleary PP
    J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.
    Zabriskie JB; Poon-King T; Blake MS; Michon F; Yoshinaga M
    Adv Exp Med Biol; 1997; 418():917-9. PubMed ID: 9331798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interrelationships between the virulence and the presence of M-protein in hemolytic streptococcus group A].
    Burova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):46-51. PubMed ID: 373337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
    Ashbaugh CD; Wessels MR
    Infect Immun; 2001 Nov; 69(11):6683-8. PubMed ID: 11598038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion.
    Medina E; Goldmann O; Toppel AW; Chhatwal GS
    J Infect Dis; 2003 Feb; 187(4):597-603. PubMed ID: 12599076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma.
    Karmarkar MG; Hule GP; Cameron A; Mehta PR; Khopkar U; Hase NK; Sriprakash KS
    BMC Infect Dis; 2015 Mar; 15():113. PubMed ID: 25849124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The OF characteristics of streptococci group A and immunity to streptococcal infection based on the results of OF and anti-OF tests].
    Krasil'nikov IA; Iontova IM; Beliakova IV; Sobolevskaia AA; Zubov AK; Stepanova TM; Fomina NI; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):26-31. PubMed ID: 2143613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of arginine deiminase in thymic atrophy during experimental Streptococcus pyogenes infection.
    Starikova EA; Golovin AS; Vasilyev KA; Karaseva AB; Serebriakova MK; Sokolov AV; Kudryavtsev IV; Burova LA; Voynova IV; Suvorov AN; Vasilyev VB; Freidlin IS
    Scand J Immunol; 2019 Feb; 89(2):e12734. PubMed ID: 30471128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current views of the etiology and pathogenesis of rheumatism. The role of streptococcal infection].
    Kutsyk RV; Dziubak ST; Neĭko EM
    Revmatologiia (Mosk); 1991; (4):25-9. PubMed ID: 1805328
    [No Abstract]   [Full Text] [Related]  

  • 18. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections.
    The Editors
    J Med Microbiol; 2000 Oct; 49(10):849-852. PubMed ID: 11023181
    [No Abstract]   [Full Text] [Related]  

  • 19. Group A streptococci: pathogenesis and immunity.
    Maxted WR
    Soc Appl Bacteriol Symp Ser; 1978; 7():107-25. PubMed ID: 364656
    [No Abstract]   [Full Text] [Related]  

  • 20. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.